OpenVSafe by OpenVAERS
Search V-safe

E9X-28165-95439

1 vaccination 2 coded responses 3 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
945 / CA
Registered
2021-01-01
Relationship
Self

Timeline

  1. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-01
    Registered in v-safe
  3. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Disorientation — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Disorientation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Acne — Feeling: Good · Site: Pain · Diarrhea, Abdominal pain
    Free text: Mild acne
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Nausea, Abdominal pain
    Adult check-in
  7. 2021-01-08

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Disorientation

2021-01-03

Systemic reaction (other): Mild acne

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAcne ✓ ✓ ✓
SRODisorientation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release